Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with radiotherapy for newly diagnosed non-1p/19q-codeleted anaplastic glioma
ACTRN12609000485235Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of temozolomide in anaplastic glioma, sponsored by University of Sydney. Started Aug 2010; status: completed.
02
Drugs
temozolomide
03
Conditions
anaplastic glioma
Beyond the preview
Go deeper on ACTRN12609000485235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000485235.